Archive · 27 Jul 2026
Brokerages Bullish on Hindustan Zinc
Hindustan Zinc Ltd (HZL) is a company that mines and processes zinc and other metals.
After their recent financial results, several brokerage firms have given their opinions on the company's stock.
Most of them think the stock will go up in value over the next year, with some predicting it could rise by nearly 20%.
However, one firm thinks the stock is already priced fairly and suggests a neutral rating.
The company is working on increasing production and controlling costs, which could help maintain profits.
Some firms believe that higher metal prices and cost control will drive earnings growth in the coming years.
Overall, the consensus is that HZL has a positive outlook, but there are some risks to consider.
Hindustan Zinc Ltd (HZL) is expected to deliver nearly 20% returns over the next 12 months.
Most brokerages have a 'Buy' or 'Neutral' rating on the stock, with a consensus target price of Rs 636.67.
HSBC has the highest target price at Rs 770, while Citi's target is the lowest at Rs 480.
Nuvama forecasts a 3% volume CAGR for refined metal and a 4% volume CAGR for silver over FY26–28.
MOFSL suggests a neutral rating, indicating that the current valuation has priced in all positive factors.
- Who
- Hindustan Zinc Ltd (HZL), brokerages including Jefferies, HSBC, Citi, 360 One Capital Markets, Nuvama, Systematix, MOFSL, Emkay Global
- What
- Brokerage firms have issued reports on Hindustan Zinc Ltd (HZL) with varying target prices and ratings.
- When
- After the Q1 earnings results
- Where
- India
- Why
- To provide investment recommendations based on HZL's performance and market conditions.
Buy Rating
Neutral Rating
Stock Performance
Buy Rating
Most brokerages recommend buying Hindustan Zinc shares due to expected high returns and favorable market conditions.
Neutral Rating
MOFSL suggests a neutral rating, indicating that the current valuation already reflects all positive factors.
- Company
- Hindustan Zinc Ltd (HZL)
- Expected Returns
- Nearly 20% over the next 12 months
- Consensus Target Price
- Rs 636.67
- Highest Target Price
- Rs 770 (HSBC)
- Lowest Target Price
- Rs 480 (Citi)
- Jefferies Target Price
- Rs 660
- 360 One Capital Markets Target Price
- Rs 725
- Nuvama Target Price
- Rs 700
- Systematix Target Price
- Rs 669
- MOFSL Target Price
- Rs 570